Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Moroni

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Blood|August 9, 2003
Kit regulatory elements required for expression in developing hematopoietic and germ cell lineagesLinda A Cairns, Emanuela Moroni, Elena Levantini, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonistsMarco Presta, Pasqua Oreste, Giorgio Zoppetti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Blood|August 9, 2003
Kit regulatory elements required for expression in developing hematopoietic and germ cell lineagesLinda A Cairns, Emanuela Moroni, Elena Levantini, et al.
Blood|November 2, 2006
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factorHelena Stabile, Stefania Mitola, Emanuela Moroni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonistsMarco Presta, Pasqua Oreste, Giorgio Zoppetti, et al.
Pageof 2